E. Ohman J or Asset Management AB Reduces Stock Position in HCA Healthcare, Inc. $HCA

E. Ohman J or Asset Management AB cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 27.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,743 shares of the company’s stock after selling 2,150 shares during the period. E. Ohman J or Asset Management AB’s holdings in HCA Healthcare were worth $2,681,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. Palisade Asset Management LLC acquired a new position in HCA Healthcare during the third quarter worth $26,000. Holos Integrated Wealth LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter worth $29,000. Harbor Capital Advisors Inc. increased its holdings in shares of HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares in the last quarter. JPL Wealth Management LLC purchased a new stake in HCA Healthcare during the third quarter worth about $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter valued at approximately $34,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the subject of a number of recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Robert W. Baird increased their target price on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. Mizuho boosted their target price on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Finally, UBS Group lifted their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. Sixteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $537.73.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $485.76 on Wednesday. The company has a market cap of $108.60 billion, a PE ratio of 17.12, a P/E/G ratio of 1.52 and a beta of 1.34. HCA Healthcare, Inc. has a 12 month low of $314.43 and a 12 month high of $556.52. The company has a fifty day moving average price of $510.56 and a two-hundred day moving average price of $475.06.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter in the prior year, the firm earned $6.22 EPS. HCA Healthcare’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is presently 10.99%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the sale, the executive vice president owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,214 shares of company stock worth $7,797,595 over the last quarter. 1.50% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.